JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wurtman, R. J.
Right arrow Articles by Anton-Tay, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wurtman, R. J.
Right arrow Articles by Anton-Tay, F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 2, 367-372, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF THE METABOLISM OF H3-MELATONIN BY PHENOTHIAZINES

Richard J. Wurtman 1, Julius Axelrod 1, and Fernando Anton-Tay 1

1 Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland, and Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts

After rats are treated acutely with chlorpromazine, there is an elevation in the level of i.v. administered H3-melatonin in brain and blood. This effect is not the result of the hypothermia produced by chlorpromazine. Other phenothiazines, such as promazine and promethazine, also elevate tissue H3-melatonin. Chlorpromazine has no effect on the level of H3-melatonin when the indole is administered to rats by injection into the lateral cerebral ventricle. Chlorpromazine inhibits the in vitro metabolism of H3-melatonin by liver slices, suggesting that the drug alters the tissue levels of the indole by slowing its metabolism. Chronic treatment with phenobarbital causes a decreased H3-melatonin concentration in the brain 30 min after i.v. injection of the indole.

Submitted on November 27, 1967
Accepted on February 9, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.